Related Experiment Videos

Overcoming treatment challenges in advanced breast cancer

Barbara Harkins1, Charles E Geyer

  • 1Protocol Development & Management, National Surgical Adjuvant Breast and Bowel Project NSABP, Pittsburg, PA 15212-5234, USA. barbara.harkins@nsabp.org

Seminars in Oncology Nursing
|January 26, 2008
PubMed
Abstract

Insights

New targeted agents like lapatinib offer improved treatment for HER2-positive metastatic breast cancer, addressing resistance to traditional therapies such as trastuzumab.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • HER2-positive breast cancer is aggressive and prone to therapy resistance.
  • Trastuzumab is the standard treatment but can face resistance.
  • Understanding resistance mechanisms is crucial for developing new therapies.

Purpose of the Study:

  • To review clinical findings, efficacy, and safety of targeted agents for HER2-positive metastatic breast cancer.
  • To highlight advancements beyond trastuzumab.
  • To inform oncology nurses about treatment strategies.

Main Methods:

  • Review of published research articles and abstracts.
  • Inclusion of clinical experience.
  • Analysis of targeted therapy mechanisms.

Main Results:

  • HER2-positive tumors are more aggressive and resistant than HER2-negative.
  • Lapatinib targets HER2 intracellularly, disrupting tumorigenic pathways.
  • Lapatinib represents a new therapeutic option for resistant cases.

Conclusions:

  • Targeted agents like lapatinib offer new treatment avenues for HER2-positive metastatic breast cancer.
  • Awareness of treatment limitations is vital for effective nursing care.
  • Continued research is needed to overcome therapeutic resistance.

Related Concept Videos

Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...